课题基金 / 基金详情

REGULATION OF P53 EXPRESSION BY THYMIDYLATE SYNTHASE

REGULATION OF P53 EXPRESSION BY THYMIDYLATE SYNTHASE
胸苷酸合成酶对 P53 表达的调节
批准号:
2861909
负责人:
JINGFANG JU
金额:
$1.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
未结题
起止时间:
1999-07-01 至

项目摘要

项目成果

JINGFANG JU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The main goal of this project is to characterize novel molecular mechanisms for the translational regulation of p53 gene expression by thymidylate synthase (TS). The main hypothesis is that, TS, in its role as a key regulatory protein, can regulate the translation of not only its own TS mRNA but also the translation of various critical cellular RNAs that are involved in cell cycle-related events including cell growth and proliferation. I will specifically focus on characterizing the interaction between TS and the mRNA of the p53 tumor suppressor gene and to determine the biological consequence(s) of this p53 RNA-TS protein interaction. Specifically, l will determine whether the interaction between TS protein and p53 mRNA will result in the translational regulation of p53. As part of this aim, l propose to characterize the potential biological consequences of translational regulation of p53 by TS, as they relate to cell cycle control, apoptosis, and chemosensitivity. Finally, the trans-acting domain(s) on TS protein that are required for binding to the p53 mRNA will be characterized. In terms of basic biology, these studies should have direct relevance in that they will provide important new insights into an increasingly described mechanism by which cellular gene expression is controlled, namely that of translational regulation. Moreover, such detailed molecular studies may provide the framework for the rational design and development of new therapeutic approaches that can be used to prevent and/or overcome the development of cellular resistance to critical antineoplastic agents such as the fluoropyrimidines and the antifolates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of novel miRNA based novel therapeutics for metastatic colorectal cancer
  • 批准号:
    10256956
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    JINGFANG JU
  • 依托单位:
Development of novel miRNA based novel therapeutics for metastatic colorectal cancer
  • 批准号:
    10512749
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    JINGFANG JU
  • 依托单位:
Roles of miR-129 in colorecal cancer
Roles of miR-129 in colorecal cancer
海外基金